查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386285

流感疫苗市場報告：2030 年趨勢、預測與競爭分析

Influenza Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

流感疫苗趨勢與預測

預計到 2030 年，全球流感疫苗市場將達到 112.2 億美元，2024 年至 2030 年複合年成長率為 6.8%。該市場的主要促進因素包括對更有效、侵入性更小的流感疫苗的需求不斷成長、人們對流感疫苗益處的認知不斷提高以及政府促進流感疫苗接種的支持措施。全球流感疫苗市場前景廣闊，醫院/零售藥局和政府供應管道都有機會。

流感疫苗市場洞察

Lucintel 預測，由於去活化疫苗的安全性和有效性，去活化疫苗的需求量很大，預計在預測期內將出現高速成長。

在這個市場中，醫院和零售藥局預計將在預測期內實現最高成長，因為它們是獲得流感疫苗最容易、最容易獲得的地點。

由於流感流行率高、醫療保健系統完善以及對疫苗接種的偏好，預計北美在預測期內將經歷最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而促使市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球流感疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球流感疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 依疫苗類型分類的全球流感疫苗市場
    • 惰性
    • 衰減
  • 依配銷通路的全球流感疫苗市場
    • 醫院和零售藥房
    • 政府供應商
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球流感疫苗市場區域分佈
  • 北美流感疫苗市場
  • 歐洲流感疫苗市場
  • 亞太地區流感疫苗市場
  • 其他區域性流感疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依疫苗類型分類的全球流感疫苗市場成長機會
    • 依配銷通路的全球流感疫苗市場成長機會
    • 全球流感疫苗市場成長機會（依地區）
  • 全球流感疫苗市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球流感疫苗市場產能擴張
    • 全球流感疫苗市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • GSK
  • AstraZeneca
  • SINOVAC
  • Pfizer
  • Vaxess Technologies
  • CSL
  • EMERGENT
簡介目錄

Influenza Vaccine Trends and Forecast

The future of the global influenza vaccine market looks promising with opportunities in the hospital & retail pharmacy and government supplier channels. The global influenza vaccine market is expected to reach an estimated $11.22 billion by 2030 with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are rising demand for more effective and less invasive influenza vaccines, growing awareness of the benefits of influenza vaccines, and supportive government initiatives to promote influenza vaccination.

A more than 150-page report is developed to help in your business decisions.

Influenza Vaccine by Segment

The study includes a forecast for the global influenza vaccine by vaccine type, distribution channel, and region.

Influenza Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Inactivated
  • Live Attenuated

Influenza Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others

Influenza Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Influenza Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies influenza vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the influenza vaccine companies profiled in this report include-

  • GSK
  • Astrazeneca
  • SINOVAC
  • Pfizer
  • Vaxess Technologies
  • CSL
  • EMERGENT

Influenza Vaccine Market Insights

Lucintel forecasts that inactivated is expected to witness higher growth over the forecast period due to growing demand for these vaccinations given to its safety and effectiveness.

Within this market, hospital & retail pharmacy is expected to witness highest growth over the forecast period as they are the easiest and most accessible locations to acquire a flu vaccine.

North America is expected to witness highest growth over the forecast period due to high prevalence of influenza, availability of well-established healthcare system, and high preference for vaccination in the region.

Features of the Global Influenza Vaccine Market

Market Size Estimates: Influenza vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Influenza vaccine market size by vaccine type, distribution channel, and region in terms of value ($B).

Regional Analysis: Influenza vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, distribution channels, and regions for the influenza vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the influenza vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the influenza vaccine market size?

Answer: The global influenza vaccine market is expected to reach an estimated $11.22 billion by 2030.

Q.2 What is the growth forecast for influenza vaccine market?

Answer: The global influenza vaccine market is expected to grow with a CAGR of 6.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the influenza vaccine market?

Answer: The major drivers for this market are rising demand for more effective and less invasive influenza vaccines, growing awareness of the benefits of influenza vaccines, and supportive government initiatives to promote influenza vaccination.

Q4. What are the major segments for influenza vaccine market?

Answer: The future of the influenza vaccine market looks promising with opportunities in the hospital & retail pharmacy and government supplier channels.

Q5. Who are the key influenza vaccine market companies?

Answer: Some of the key influenza vaccine companies are as follows:

  • GSK
  • Astrazeneca
  • SINOVAC
  • Pfizer
  • Vaxess Technologies
  • CSL
  • EMERGENT

Q6. Which influenza vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that inactivated is expected to witness higher growth over the forecast period due to growing demand for these vaccinations given to its safety and effectiveness.

Q7. In influenza vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of influenza, availability of well-established healthcare system, and high preference for vaccination in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the influenza vaccine market by vaccine type (inactivated and live attenuated), distribution channel (hospital & retail pharmacies, government suppliers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Influenza Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Influenza Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Influenza Vaccine Market by Vaccine Type
    • 3.3.1: Inactivated
    • 3.3.2: Live Attenuated
  • 3.4: Global Influenza Vaccine Market by Distribution Channel
    • 3.4.1: Hospital & Retail Pharmacies
    • 3.4.2: Government Suppliers
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Influenza Vaccine Market by Region
  • 4.2: North American Influenza Vaccine Market
    • 4.2.2: North American Influenza Vaccine Market by Distribution Channel: Hospital & Retail Pharmacies, Government Suppliers, and Others
  • 4.3: European Influenza Vaccine Market
    • 4.3.1: European Influenza Vaccine Market by Vaccine Type: Inactivated and Live Attenuated
    • 4.3.2: European Influenza Vaccine Market by Distribution Channel: Hospital & Retail Pharmacies, Government Suppliers, and Others
  • 4.4: APAC Influenza Vaccine Market
    • 4.4.1: APAC Influenza Vaccine Market by Vaccine Type: Inactivated and Live Attenuated
    • 4.4.2: APAC Influenza Vaccine Market by Distribution Channel: Hospital & Retail Pharmacies, Government Suppliers, and Others
  • 4.5: ROW Influenza Vaccine Market
    • 4.5.1: ROW Influenza Vaccine Market by Vaccine Type: Inactivated and Live Attenuated
    • 4.5.2: ROW Influenza Vaccine Market by Distribution Channel: Hospital & Retail Pharmacies, Government Suppliers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Influenza Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Influenza Vaccine Market by Distribution Channel
    • 6.1.3: Growth Opportunities for the Global Influenza Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Influenza Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Influenza Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Influenza Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GSK
  • 7.2: AstraZeneca
  • 7.3: SINOVAC
  • 7.4: Pfizer
  • 7.5: Vaxess Technologies
  • 7.6: CSL
  • 7.7: EMERGENT